Purchase Order 75N93024P00795
Award Date
7/5/24
Potential Completion Date
7/4/25
Potential Value
$94K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a NEXTSEQ 2000 SILVER SUPPORT PLAN. The potential value of the contract is $48,209.00, with a completion date of April 2, 2025. This contract is not set aside and is for the provision of sequencing and array-based solutions to support genomic analysis and life science research. Illumina, a for-profit...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $4,037.50, is for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and support services. The contract has no set-aside designation....
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $5,636.16 contract is for the delivery of Illumina's sequencing systems, reagents, and services to support genomic research and analysis. Illumina, a manufacturer of genetic analysis instruments and consumables, has previously been awarded prime contracts and sub-awards across various federal agencies...
This is a $6,935.22 firm fixed-price purchase order contract awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH). The contract, which has no set-aside designation, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies. Illumina has...
This is a $863,550.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) to Illumina, Inc. for the provision of lab equipment, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and other consumables. Illumina is a manufacturer and provider of genomic sequencing and analysis solutions. The award has no set-aside designation. Illumina has a history of providing...
This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer and provider of genetic and genomic analysis solutions. The $5,834.40 order is for the provision of Illumina's sequencing instruments, reagents, and services, including NextSeq, NovaSeq, MiSeq, and iSeq systems. These products and services support genomic sequencing and analysis for...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The $5,212.06 contract is for the provision of next-generation sequencing kits to support genomic research and diagnostics. Illumina has a history of providing sequencing systems, reagents, and associated services to federal agencies...
This is a $14,997.46 firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The contract is not set aside for any specific business size or type. Under this award, Illumina will provide a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits,...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for a NextSeq 2000 Silver Support Plan and Preventive Maintenance with a total ceiling value of $23,717.81. The award does not utilize any set-aside designations. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has received prior prime federal contract and sub-grant awards...